Process for preparing pyrazoles
US-2017210712-A1 · Jul 27, 2017 · US
US10513498B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10513498-B2 |
| Application number | US-201916292773-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 5, 2019 |
| Priority date | Jul 31, 2014 |
| Publication date | Dec 24, 2019 |
| Grant date | Dec 24, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a process for preparing a pyrazole compound of formula V, which comprises cyclizing a hydrazone substituted α,β-unsaturated carbonyl compound of formula IV by reacting it with a suitable reagent, e.g. a reducing agent, an organometallic reagent or a nucleophilic reagent. The compounds of formula V are versatile reaction tools for the preparation of pyrazole derived fine chemicals. The present invention also relates to pyrazole compounds of formulae Va, Vb, Vc, and VI.
Opening claim text (preview).
The invention claimed is: 1. A compound of formula V or a salt, stereoisomer, tautomer or N-oxide thereof wherein R 2 is CH 3 , R 3 is H, R 4 is CH(CH 3 ) 2 , R 5 is CH 3 and R 6 is H; or R 2 is CH 3 , R 3 is H, R 4 is CHFCH 3 , R 5 is CH 3 and R 6 is H; or R 2 is CH 3 , R 3 is H, R 4 is 1-CN-cC 3 H 4 , R 5 is CH 3 and R 6 is H; or R 2 is CH 3 , R 3 is H, R 4 is 1-C(O)NH 2 -cC 3 H 4 , R 5 is CH 3 and R 6 is H; or R 2 is CH 3 , R 3 is H, R 4 and R 5 together are CH 2 CH 2 CF 2 CH 2 CH 2 , and R 6 is H; wherein R 1 is CN or COOR c ; R c is H, C 1 -C 4 -alkyl or aryl-C 1 -C 4 -alkyl, or wherein R c together with the C(O)O group forms a salt [C(O)O] − NR 4 + , [C(O)O] − M a + or [C(O)O] − ½M ea 2+ , wherein M a is an alkali metal and M ea is an alkaline earth metal. 2. The compound of claim 1 , wherein said compound has formula Va or a salt, stereoisomer, tautomer or N-oxide thereof wherein R 2 is CH 3 , R 3 is H, R 4 is CH(CH 3 ) 2 , R 5 is CH 3 and R 6 is H; or R 2 is CH 3 , R 3 is H, R 4 is CHFCH 3 , R 5 is CH 3 and R 6 is H; or R 2 is CH 3 , R 3 is H, R 4 is 1-CN-cC 3 H 4 , R 5 is CH 3 and R 6 is H; or R 2 is CH 3 , R 3 is H, R 4 is 1-C(O)NH 2 -cC 3 H 4 , R 5 is CH 3 and R 6 is H; or R 2 is CH 3 , R 3 is H, R 4 and R 5 together are CH 2 CH 2 CF 2 CH 2 CH 2 , and R 6 is H; and wherein R c is C 1 -C 4 -alkyl or aryl-C 1 -C 4 -alkyl, or wherein R c together with the C(O)O group forms a salt [C(O)O] − NR 4 + , [C(O)O] − M a + or [C(O)O] − ½M ea 2+ , wherein M a is an alkali metal and M ea is an alkaline earth metal. 3. The compound of claim 1 , wherein said compound has formula Vc or a salt, stereoisomer, tautomer or N-oxide thereof wherein R 2 is CH 3 , R 3 is H, R 4 is CH(CH 3 ) 2 , R 5 is CH 3 and R 6 is H; or R 2 is CH 3 , R 3 is H, R 4 is CHFCH 3 , R 5 is CH 3 and R 6 is H; or R 2 is CH 3 , R 3 is H, R 4 is 1-CN-cC 3 H 4 , R 5 is CH 3 and R 6 is H; or R 2 is CH 3 , R 3 is H, R 4 is 1-C(O)NH 2 -cC 3 H 4 , R 5 is CH 3 and R 6 is H; or R 2 is CH 3 , R 3 is H, R 4 and R 5 together are CH 2 CH 2 CF 2 CH 2 CH 2 , and R 6 is H. 4. The compound of claim 1 , wherein said compound has formula Vb or a salt, stereoisomer, tautomer or N-oxide thereof wherein R 2 is CH 3 , R 3 is H, R 4 is CH(CH 3 ) 2 , R 5 is CH 3 and R 6 is H; or R 2 is CH 3 , R 3 is H, R 4 is CHFCH 3 , R 5 is CH 3 and R 6 is H; or R 2 is CH 3 , R 3 is H, R 4 is 1-CN-cC 3 H 4 , R 5 is CH 3 and R 6 is H; or R 2 is CH 3 , R 3 is H, R 4 is 1-C(O)NH 2 -cC 3 H 4 , R 5 is CH 3 and R 6 is H; or R 2 is CH 3 , R 3 is H, R 4 and R 5 together are CH 2 CH 2 CF 2 CH 2 CH 2 , and R 6 is H. 5. A compound of formula IV or a salt, stereoisomer, tautomer or N-oxide thereof wherein R 1 is CN, C(O)OCH 3 , C(O)OCH 2 CH 3 , C(O)OC(CH 3 ) 3 , C(O)OCH 2 C 6 H 5 , or COOH; R 2 is CH 3 , R 3 is H, and R 4 is CH(CH 3 ) 2 , and R 5 is CH 3 ; or R 4 is CHFCH 3 , and R 5 is CH 3 ; or R 4 is 1-CN-cC 3 H 4 , and R 5 is CH 3 ; or R 4 is 1-C(O)NH 2 -cC 3 H 4 , and R 5 is CH 3 ; or R 4 and R 5 together are CH 2 CH 2 CF 2 CH 2 CH 2 .
linked by a carbon chain containing only aliphatic carbon atoms · CPC title
linked by a chain containing hetero atoms as chain links · CPC title
linked by a chain containing hetero atoms as chain links · CPC title
with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms · CPC title
1,2-Diazoles; Hydrogenated 1,2-diazoles · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.